Skip to main content

ANALISIS DE REDES COMPARATIVO E INTEGRATIVO MULTIOMICO MULTIESCALA

PID2019-105500GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION

Resultados relacionados

Resultados totales (Incluyendo duplicados): 18
Encontrada(s) 1 página(s)

UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma

  • Gureghian, Vincent
  • Herbst, Hailee
  • Kozar, Ines
  • Mihajlović, Katarina
  • Malod-Dognin, Noël
  • Ceddia, Gaia
  • Pržulj, Nataša
Therapy Induced Senescence (TIS) leads to sustained growth arrest of cancer cells. The associated cytostasis has been shown to be reversible and cells escaping senescence further enhance the aggressiveness of cancers. Chemicals specifically targeting senescent cells, so-called senolytics, constitute a promising avenue for improved cancer treatment in combination with targeted therapies. Understanding how cancer cells evade senescence is needed to optimise the clinical benefits of this therapeutic approach. Here we characterised the response of three different NRAS mutant melanoma cell lines to a combination of CDK4/6 and MEK inhibitors over 33 days. Transcriptomic data show that all cell lines trigger a senescence programme coupled with strong induction of interferons. Kinome profiling revealed the activation of Receptor Tyrosine Kinases (RTKs) and enriched downstream signaling of neurotrophin, ErbB and insulin pathways. Characterisation of the miRNA interactome associates miR-211-5p with resistant phenotypes. Finally, iCell-based integration of bulk and single-cell RNA-seq data identifies biological processes perturbed during senescence and predicts 90 new genes involved in its escape. Overall, our data associate insulin signaling with persistence of a senescent phenotype and suggest a new role for interferon gamma in senescence escape through the induction of EMT and the activation of ERK5 signaling., VG is supported by the Luxembourg National Research Fond (FNR) PRIDE DTU CanBIO [grant reference: 21/16763386]. TR is supported by the FNR PRIDE DTU CriTiCS [grant reference: 10907093]. Project-related work performed by VG, HH, CM, DP, MTN, MB, AG, FT and SK were also supported by the University of Luxembourg and the Fondation Cancer, Luxembourg (grant “SecMelPro”). KM and NP are supported by funding from the European Union’s EU Framework Programme for Research and Innovation Horizon 2020, Innovative Training Networks (MSCA-ITN-2019), funded under EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, Grant Agreement No 860895. KM, NMD, GC and NP are supported by funding from the European Research Council (ERC) Consolidator Grant 770827. NP is also supported by funding from the Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00., Peer Reviewed, "Article signat per 22 autors/es: Vincent Gureghian, Hailee Herbst, Ines Kozar, Katarina Mihajlovic, Noël Malod-Dognin, Gaia Ceddia, Cristian Angeli, Christiane Margue, Tijana Randic, Demetra Philippidou, Milène Tetsi Nomigni, Ahmed Hemedan, Leon-Charles Tranchevent, Joseph Longworth, Mark Bauer, Apurva Badkas, Anthoula Gaigneaux, Arnaud Muller, Marek Ostaszewski, Fabrice Tolle, Nataša Pržulj & Stephanie Kreis"
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Graphlet-based hyperbolic embeddings capture evolutionary dynamics in genetic networks

  • Windels, Sam F L
  • Tello Velázquez, Daniel
  • Rotkevich, Mikhail
  • Malod Dognin, Noël
  • Przulj, Natasa|||0000-0002-1290-853X
Motivation Spatial Analysis of Functional Enrichment (SAFE) is a popular tool for biologists to investigate the functional organization of biological networks via highly intuitive 2D functional maps. To create these maps, SAFE uses Spring embedding to project a given network into a 2D space in which nodes connected in the network are near each other in space. However, many biological networks are scale-free, containing highly connected hub nodes. Because Spring embedding fails to separate hub nodes, it provides uninformative embeddings that resemble a ‘hairball’. In addition, Spring embedding only captures direct node connectivity in the network and does not consider higher-order node wiring patterns, which are best captured by graphlets, small, connected, nonisomorphic, induced subgraphs. The scale-free structure of biological networks is hypothesized to stem from an underlying low-dimensional hyperbolic geometry, which novel hyperbolic embedding methods try to uncover. These include coalescent embedding, which projects a network onto a 2D disk. Results To better capture the functional organization of scale-free biological networks, whilst also going beyond simple direct connectivity patterns, we introduce Graphlet Coalescent (GraCoal) embedding, which embeds nodes nearby on a disk if they frequently co-occur on a given graphlet together. We use GraCoal to extend SAFE-based network analysis. Through SAFE-enabled enrichment analysis, we show that GraCoal outperforms graphlet-based Spring embedding in capturing the functional organization of the genetic interaction networks of fruit fly, budding yeast, fission yeast and Escherichia coli. We show that depending on the underlying graphlet, GraCoal embeddings capture different topology-function relationships. We show that triangle-based GraCoal embedding captures functional redundancies between paralogs., This work was supported by the European Research Council (ERC) Consolidator Grant [770827] and the Spanish State Research Agency AEI 10.13039/501100011033 grant number [PID2019-105500GB-I00]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

A functional analysis of omic network embedding spaces reveals key altered functions in cancer

  • Doria Belenguer, Sergio
  • Xenos, Alexandros
  • Ceddia, Gaia
  • Malod Dognin, Noël
  • Pržulj, Nataša
Abstract Motivation Advances in omics technologies have revolutionized cancer research by producing massive datasets. Common approaches to deciphering these complex data are by embedding algorithms of molecular interaction networks. These algorithms find a low-dimensional space in which similarities between the network nodes are best preserved. Currently available embedding approaches mine the gene embeddings directly to uncover new cancer-related knowledge. However, these gene-centric approaches produce incomplete knowledge, since they do not account for the functional implications of genomic alterations. We propose a new, function-centric perspective and approach, to complement the knowledge obtained from omic data. Results We introduce our Functional Mapping Matrix (FMM) to explore the functional organization of different tissue-specific and species-specific embedding spaces generated by a Non-negative Matrix Tri-Factorization algorithm. Also, we use our FMM to define the optimal dimensionality of these molecular interaction network embedding spaces. For this optimal dimensionality, we compare the FMMs of the most prevalent cancers in human to FMMs of their corresponding control tissues. We find that cancer alters the positions in the embedding space of cancer-related functions, while it keeps the positions of the noncancer-related ones. We exploit this spacial ‘movement’ to predict novel cancer-related functions. Finally, we predict novel cancer-related genes that the currently available methods for gene-centric analyses cannot identify; we validate these predictions by literature curation and retrospective analyses of patient survival data., This project has received funding from the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Integrated data analysis uncovers new COVID-19 related genes and potential drug re-purposing candidates

  • Xenos, Alexandros
  • Malod Dognin, Noël
  • Zambrana Seguí, Maria del Carme
  • Pržulj, Nataša
The COVID-19 pandemic is an acute and rapidly evolving global health crisis. To better understand this disease’s molecular basis and design therapeutic strategies, we built upon the recently proposed concept of an integrated cell, iCell, fusing three omics, tissue-specific human molecular interaction networks. We applied this methodology to construct infected and control iCells using gene expression data from patient samples and three cell lines. We found large differences between patient-based and cell line-based iCells (both infected and control), suggesting that cell lines are ill-suited to studying this disease. We compared patient-based infected and control iCells and uncovered genes whose functioning (wiring patterns in iCells) is altered by the disease. We validated in the literature that 18 out of the top 20 of the most rewired genes are indeed COVID-19-related. Since only three of these genes are targets of approved drugs, we applied another data fusion step to predict drugs for re-purposing. We confirmed with molecular docking that the predicted drugs can bind to their predicted targets. Our most interesting prediction is artenimol, an antimalarial agent targeting ZFP62, one of our newly identified COVID-19-related genes. This drug is a derivative of artemisinin drugs that are already under clinical investigation for their potential role in the treatment of COVID-19. Our results demonstrate further applicability of the iCell framework for integrative comparative studies of human diseases., This work was supported by the European Research Council (ERC) Consolidator Grant 770827, and the Spanish State Research Agency AEI 10.13039/501100011033, grant number PID2019-105500GB-I00., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson’s disease

  • Mihajlović, Katarina
  • Ceddia, Gaia
  • Malod Dognin, Noël
  • Novak, Gabriela
  • Kyriakis, Dimitrios
  • Skupin, Alexander
  • Przulj, Natasa|||0000-0002-1290-853X
Parkinson’s disease (PD) is a complex neurodegenerative disorder without a cure. The onset of PD symptoms corresponds to 50% loss of midbrain dopaminergic (mDA) neurons, limiting early-stage understanding of PD. To shed light on early PD development, we study time series scRNA-seq datasets of mDA neurons obtained from patient-derived induced pluripotent stem cell differentiation. We develop a new data integration method based on Non-negative Matrix Tri-Factorization that integrates these datasets with molecular interaction networks, producing condition-specific “gene embeddings”. By mining these embeddings, we predict 193 PD-related genes that are largely supported (49.7%) in the literature and are specific to the investigated PINK1 mutation. Enrichment analysis in Kyoto Encyclopedia of Genes and Genomes pathways highlights 10 PD-related molecular mechanisms perturbed during early PD development. Finally, investigating the top 20 prioritized genes reveals 12 previously unrecognized genes associated with PD that represent interesting drug targets., This project has received funding from the European Union’s EU Framework Programme for Research and Innovation Horizon 2020, Grant Agreement No 860895, the European Research Council (ERC) Consolidator Grant 770827, the Spanish State Research Agency and the Ministry of Science and Innovation MCIN grant PID2019-105500GB-I00 / AEI / 10.13039/501100011033 and grant PID2022-141920NB-I00 / AEI /10.13039/501100011033/ FEDER, UE, and the Department of Research and Universities of the Generalitat de Catalunya code 2021 SGR 01536. DK was supported by the PRIDE program of the Luxembourg National Research Fund through PRIDE17/12244779/PARK-QC., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Big Data to Knowledge Analytics Reveals the Zika Virus Epidemic as Only One of Multiple Factors Contributing to a Year-Over-Year 28-Fold Increase in Microcephaly Incidence

  • Cifuentes, Myriam Patricia
  • Suarez, Clara Mercedes
  • Cifuentes, Ricardo
  • Malod-Dognin, Noel
  • Windels, Sam
  • Pržulj, Natasa
During the 2015–2016 Zika Virus (ZIKV) epidemic in Brazil, the geographical distributions of ZIKV infection and microcephaly outbreaks did not align. This raised doubts about the virus as the single cause of the microcephaly outbreak and led to research hypotheses of alternative explanatory factors, such as environmental variables and factors, agrochemical use, or immunizations. We investigated context and the intermediate and structural determinants of health inequalities, as well as social environment factors, to determine their interaction with ZIKV-positive- and ZIKV-negative-related microcephaly. The results revealed the identification of 382 associations among 382 nonredundant variables of Zika surveillance, including multiple determinants of environmental public health factors and variables obtained from 5565 municipalities in Brazil. This study compared those factors and variables directly associated with microcephaly incidence positive to ZIKV and those associated with microcephaly incidence negative to ZIKV, respectively, and mapped them in case and control subnetworks. The subnetworks of factors and variables associated with low birth weight and birthweight where birth incidence served as an additional control were also mapped. Non-significant differences in factors and variables were observed, as were weights of associations between microcephaly incidence, both positive and negative to ZIKV, which revealed diagnostic inaccuracies that translated to the underestimation of the scope of the ZIKV outbreak. A detailed analysis of the patterns of association does not support a finding that vaccinations contributed to microcephaly, but it does raise concerns about the use of agrochemicals as a potential factor in the observed neurotoxicity arising from the presence of heavy metals in the environment and microcephaly not associated with ZIKV. Summary: A comparative network inferential analysis of the patterns of variables and factors associated with Zika virus infections in Brazil during 2015–2016 coinciding with a microcephaly epidemic identified multiple contributing determinants. This study advances our understanding of the cumulative interactive effects of exposures to chemical and non-chemical stressors in the built, natural, physical, and social environments on adverse pregnancy and health outcomes in vulnerable populations., The Institute for Health Disparities, Equity and the Exposome at Meharry Medical College and researchers at The Ohio State University would like to acknowledge partial support from USEPA STAR Grant# G17D112354237 for Co-Principal Investigator Darryl B. Hood, and Co-Investigator Cynthia Colen. We also acknowledge support for N.P. from The European Research Council (ERC) Consolidator Grant 770827 and The Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results., Peer Reviewed, "Article signat per 16 autors/es: Myriam Patricia Cifuentes, Clara Mercedes Suarez, Ricardo Cifuentes, Noel Malod-Dognin ,Sam Windels, Jose Fernando Valderrama ,Paul D. Juarez, R. Burciaga Valdez ,Cynthia Colen,Charles Phillips,Aramandla Ramesh,Wansoo Im ,Maureen Lichtveld, Charles Mouton,Nataša Pržulj and Darryl B. Hood "
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Drugst.One — a plug-and-play solution for online systems medicine and network-based drug repurposing

  • Maier, Andreas
  • Hartung, Michael
  • Abovsky, Mark
  • Adamowicz, Klaudia
  • Bader, Gary D
  • Garcia Hernandez, Carlos
  • Malod Dognin, Noel
  • Przulj, Natasa|||0000-0002-1290-853X
In recent decades, the de v elopment of ne w drugs has become increasingly e xpensiv e and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools ha v e emerged to identify potential drug repurposing candidates. Ho w e v er, these tools often require complex installation and lack intuitive visual network mining capabilities. To tac kle these c hallenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing . W ith just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adapt abilit y, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://dr ugst.one , Dr ugst.One has significant potential for streamlining the drug disco v ery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research., REPO-TRIAL: this project has received funding from the European Union’s Horizon 2020 research and innovation programme [777111]; this publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains; RePo4EU: this project is funded by the European Union [101057619]; views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them; Swiss State Secretariat for Education, Research and Innovation (SERI) [22.00115]; German Federal Ministry of Education and Research (BMBF) within the framework of ‘CLINSPECT-M/-2’ [F031L0214A, 161L0214A, 16LW0243K]; Technical University Munich – Institute for Advanced Study, funded by the German Excellence Initiative; Intramural Research Programs (IRPs) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [422216132]; J.B. was partially funded by his VILLUM Young Investigator Grant [13154]; European Research Council (ERC) Consolidator Grant [770827]; Spanish State Research Agency AEI 10.13039/501100011033 [PID2019-105500GB-I00]; I.J. was supported in part by funding from Natural Sciences Research Council [NSERC #203475], Canada Foundation for Innovation [CFI #225404, #30865]; Ontario Research Fund [RDI #34876, RE010-020]; IBM and Ian Lawson van Toch Fund; S.L. has received funding from the European Union’s Horizon 2020 research and innovation programme [965193] for DECIDER. Funding for open access charge: Horizon Europe project Repo4EU., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Identifying cellular cancer mechanisms through pathway-driven data integration

  • Windels, Sam F
  • Malod Dognin, Noël
  • Pržulj, Nataša
Motivation Cancer is a genetic disease in which accumulated mutations of driver genes induce a functional reorganization of the cell by reprogramming cellular pathways. Current approaches identify cancer pathways as those most internally perturbed by gene expression changes. However, driver genes characteristically perform hub roles between pathways. Therefore, we hypothesize that cancer pathways should be identified by changes in their pathway–pathway relationships. Results To learn an embedding space that captures the relationships between pathways in a healthy cell, we propose pathway-driven non-negative matrix tri-factorization. In this space, we determine condition-specific (i.e. diseased and healthy) embeddings of pathways and genes. Based on these embeddings, we define our ‘NMTF centrality’ to measure a pathway’s or gene’s functional importance, and our ‘moving distance’, to measure the change in its functional relationships. We combine both measures to predict 15 genes and pathways involved in four major cancers, predicting 60 gene–cancer associations in total, covering 28 unique genes. To further exploit driver genes’ tendency to perform hub roles, we model our network data using graphlet adjacency, which considers nodes adjacent if their interaction patterns form specific shapes (e.g. paths or triangles). We find that the predicted genes rewire pathway–pathway interactions in the immune system and provide literary evidence that many are druggable (15/28) and implicated in the associated cancers (47/60). We predict six druggable cancer-specific drug targets., This work was supported by the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 [grant number PID2019-105500GB-I00]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Identifying cellular cancer mechanisms through pathway-driven data integration

  • Windels, Sam F L
  • Malod Dognin, Noël
  • Przulj, Natasa|||0000-0002-1290-853X
Abstract Motivation Cancer is a genetic disease in which accumulated mutations of driver genes induce a functional reorganization of the cell by reprogramming cellular pathways. Current approaches identify cancer pathways as those most internally perturbed by gene expression changes. However, driver genes characteristically perform hub roles between pathways. Therefore, we hypothesize that cancer pathways should be identified by changes in their pathway–pathway relationships. Results To learn an embedding space that captures the relationships between pathways in a healthy cell, we propose pathway-driven non-negative matrix tri-factorization. In this space, we determine condition-specific (i.e. diseased and healthy) embeddings of pathways and genes. Based on these embeddings, we define our ‘NMTF centrality’ to measure a pathway’s or gene’s functional importance, and our ‘moving distance’, to measure the change in its functional relationships. We combine both measures to predict 15 genes and pathways involved in four major cancers, predicting 60 gene–cancer associations in total, covering 28 unique genes. To further exploit driver genes’ tendency to perform hub roles, we model our network data using graphlet adjacency, which considers nodes adjacent if their interaction patterns form specific shapes (e.g. paths or triangles). We find that the predicted genes rewire pathway–pathway interactions in the immune system and provide literary evidence that many are druggable (15/28) and implicated in the associated cancers (47/60). We predict six druggable cancer-specific drug targets., This work was supported by the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 [grant number PID2019-105500GB-I00]., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Drugst.One — a plug-and-play solution for online systems medicine and network-based drug repurposing

  • Maier, Andreas
  • Hartung, Michael
  • Abovsky, Mark
  • Adamowicz, Klaudia
  • Bader, Gary D
  • Garcia Hernandez, Carlos
  • Malod Dognin, Noel
  • Przulj, Natasa
In recent decades, the de v elopment of ne w drugs has become increasingly e xpensiv e and inefficient, and the molecular mechanisms of most pharmaceuticals remain poorly understood. In response, computational systems and network medicine tools ha v e emerged to identify potential drug repurposing candidates. Ho w e v er, these tools often require complex installation and lack intuitive visual network mining capabilities. To tac kle these c hallenges, we introduce Drugst.One, a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing . W ith just three lines of code, Drugst.One turns any systems biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks. Demonstrating its broad adapt abilit y, Drugst.One has been successfully integrated with 21 computational systems medicine tools. Available at https://dr ugst.one , Dr ugst.One has significant potential for streamlining the drug disco v ery process, allowing researchers to focus on essential aspects of pharmaceutical treatment research., REPO-TRIAL: this project has received funding from the European Union’s Horizon 2020 research and innovation programme [777111]; this publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains; RePo4EU: this project is funded by the European Union [101057619]; views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them; Swiss State Secretariat for Education, Research and Innovation (SERI) [22.00115]; German Federal Ministry of Education and Research (BMBF) within the framework of ‘CLINSPECT-M/-2’ [F031L0214A, 161L0214A, 16LW0243K]; Technical University Munich – Institute for Advanced Study, funded by the German Excellence Initiative; Intramural Research Programs (IRPs) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [422216132]; J.B. was partially funded by his VILLUM Young Investigator Grant [13154]; European Research Council (ERC) Consolidator Grant [770827]; Spanish State Research Agency AEI 10.13039/501100011033 [PID2019-105500GB-I00]; I.J. was supported in part by funding from Natural Sciences Research Council [NSERC #203475], Canada Foundation for Innovation [CFI #225404, #30865]; Ontario Research Fund [RDI #34876, RE010-020]; IBM and Ian Lawson van Toch Fund; S.L. has received funding from the European Union’s Horizon 2020 research and innovation programme [965193] for DECIDER. Funding for open access charge: Horizon Europe project Repo4EU., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Integrated data analysis uncovers new COVID-19 related genes and potential drug re-purposing candidates

  • Xenos, Alexandros
  • Malod Dognin, Noël
  • Zambrana Seguí, Maria del Carme
  • Pržulj, Nataša
The COVID-19 pandemic is an acute and rapidly evolving global health crisis. To better understand this disease’s molecular basis and design therapeutic strategies, we built upon the recently proposed concept of an integrated cell, iCell, fusing three omics, tissue-specific human molecular interaction networks. We applied this methodology to construct infected and control iCells using gene expression data from patient samples and three cell lines. We found large differences between patient-based and cell line-based iCells (both infected and control), suggesting that cell lines are ill-suited to studying this disease. We compared patient-based infected and control iCells and uncovered genes whose functioning (wiring patterns in iCells) is altered by the disease. We validated in the literature that 18 out of the top 20 of the most rewired genes are indeed COVID-19-related. Since only three of these genes are targets of approved drugs, we applied another data fusion step to predict drugs for re-purposing. We confirmed with molecular docking that the predicted drugs can bind to their predicted targets. Our most interesting prediction is artenimol, an antimalarial agent targeting ZFP62, one of our newly identified COVID-19-related genes. This drug is a derivative of artemisinin drugs that are already under clinical investigation for their potential role in the treatment of COVID-19. Our results demonstrate further applicability of the iCell framework for integrative comparative studies of human diseases., This work was supported by the European Research Council (ERC) Consolidator Grant 770827, and the Spanish State Research Agency AEI 10.13039/501100011033, grant number PID2019-105500GB-I00., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identifying cellular cancer mechanisms through pathway-driven data integration

  • Windels, Sam F L
  • Malod Dognin, Noël
  • Przulj, Natasa
Abstract Motivation Cancer is a genetic disease in which accumulated mutations of driver genes induce a functional reorganization of the cell by reprogramming cellular pathways. Current approaches identify cancer pathways as those most internally perturbed by gene expression changes. However, driver genes characteristically perform hub roles between pathways. Therefore, we hypothesize that cancer pathways should be identified by changes in their pathway–pathway relationships. Results To learn an embedding space that captures the relationships between pathways in a healthy cell, we propose pathway-driven non-negative matrix tri-factorization. In this space, we determine condition-specific (i.e. diseased and healthy) embeddings of pathways and genes. Based on these embeddings, we define our ‘NMTF centrality’ to measure a pathway’s or gene’s functional importance, and our ‘moving distance’, to measure the change in its functional relationships. We combine both measures to predict 15 genes and pathways involved in four major cancers, predicting 60 gene–cancer associations in total, covering 28 unique genes. To further exploit driver genes’ tendency to perform hub roles, we model our network data using graphlet adjacency, which considers nodes adjacent if their interaction patterns form specific shapes (e.g. paths or triangles). We find that the predicted genes rewire pathway–pathway interactions in the immune system and provide literary evidence that many are druggable (15/28) and implicated in the associated cancers (47/60). We predict six druggable cancer-specific drug targets., This work was supported by the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 [grant number PID2019-105500GB-I00]., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A multi-omics integrative approach unravels novel genes and pathways associated with senescence escape after targeted therapy in NRAS mutant melanoma

  • Gureghian, Vincent
  • Herbst, Hailee
  • Kozar, Ines
  • Mihajlović, Katarina
  • Malod-Dognin, Noël
  • Ceddia, Gaia
  • Pržulj, Nataša
Therapy Induced Senescence (TIS) leads to sustained growth arrest of cancer cells. The associated cytostasis has been shown to be reversible and cells escaping senescence further enhance the aggressiveness of cancers. Chemicals specifically targeting senescent cells, so-called senolytics, constitute a promising avenue for improved cancer treatment in combination with targeted therapies. Understanding how cancer cells evade senescence is needed to optimise the clinical benefits of this therapeutic approach. Here we characterised the response of three different NRAS mutant melanoma cell lines to a combination of CDK4/6 and MEK inhibitors over 33 days. Transcriptomic data show that all cell lines trigger a senescence programme coupled with strong induction of interferons. Kinome profiling revealed the activation of Receptor Tyrosine Kinases (RTKs) and enriched downstream signaling of neurotrophin, ErbB and insulin pathways. Characterisation of the miRNA interactome associates miR-211-5p with resistant phenotypes. Finally, iCell-based integration of bulk and single-cell RNA-seq data identifies biological processes perturbed during senescence and predicts 90 new genes involved in its escape. Overall, our data associate insulin signaling with persistence of a senescent phenotype and suggest a new role for interferon gamma in senescence escape through the induction of EMT and the activation of ERK5 signaling., VG is supported by the Luxembourg National Research Fond (FNR) PRIDE DTU CanBIO [grant reference: 21/16763386]. TR is supported by the FNR PRIDE DTU CriTiCS [grant reference: 10907093]. Project-related work performed by VG, HH, CM, DP, MTN, MB, AG, FT and SK were also supported by the University of Luxembourg and the Fondation Cancer, Luxembourg (grant “SecMelPro”). KM and NP are supported by funding from the European Union’s EU Framework Programme for Research and Innovation Horizon 2020, Innovative Training Networks (MSCA-ITN-2019), funded under EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions, Grant Agreement No 860895. KM, NMD, GC and NP are supported by funding from the European Research Council (ERC) Consolidator Grant 770827. NP is also supported by funding from the Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00., Peer Reviewed, "Article signat per 22 autors/es: Vincent Gureghian, Hailee Herbst, Ines Kozar, Katarina Mihajlovic, Noël Malod-Dognin, Gaia Ceddia, Cristian Angeli, Christiane Margue, Tijana Randic, Demetra Philippidou, Milène Tetsi Nomigni, Ahmed Hemedan, Leon-Charles Tranchevent, Joseph Longworth, Mark Bauer, Apurva Badkas, Anthoula Gaigneaux, Arnaud Muller, Marek Ostaszewski, Fabrice Tolle, Nataša Pržulj & Stephanie Kreis", Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Big Data to Knowledge Analytics Reveals the Zika Virus Epidemic as Only One of Multiple Factors Contributing to a Year-Over-Year 28-Fold Increase in Microcephaly Incidence

  • Cifuentes, Myriam Patricia
  • Suarez, Clara Mercedes
  • Cifuentes, Ricardo
  • Malod-Dognin, Noel
  • Windels, Sam
  • Pržulj, Natasa
During the 2015–2016 Zika Virus (ZIKV) epidemic in Brazil, the geographical distributions of ZIKV infection and microcephaly outbreaks did not align. This raised doubts about the virus as the single cause of the microcephaly outbreak and led to research hypotheses of alternative explanatory factors, such as environmental variables and factors, agrochemical use, or immunizations. We investigated context and the intermediate and structural determinants of health inequalities, as well as social environment factors, to determine their interaction with ZIKV-positive- and ZIKV-negative-related microcephaly. The results revealed the identification of 382 associations among 382 nonredundant variables of Zika surveillance, including multiple determinants of environmental public health factors and variables obtained from 5565 municipalities in Brazil. This study compared those factors and variables directly associated with microcephaly incidence positive to ZIKV and those associated with microcephaly incidence negative to ZIKV, respectively, and mapped them in case and control subnetworks. The subnetworks of factors and variables associated with low birth weight and birthweight where birth incidence served as an additional control were also mapped. Non-significant differences in factors and variables were observed, as were weights of associations between microcephaly incidence, both positive and negative to ZIKV, which revealed diagnostic inaccuracies that translated to the underestimation of the scope of the ZIKV outbreak. A detailed analysis of the patterns of association does not support a finding that vaccinations contributed to microcephaly, but it does raise concerns about the use of agrochemicals as a potential factor in the observed neurotoxicity arising from the presence of heavy metals in the environment and microcephaly not associated with ZIKV. Summary: A comparative network inferential analysis of the patterns of variables and factors associated with Zika virus infections in Brazil during 2015–2016 coinciding with a microcephaly epidemic identified multiple contributing determinants. This study advances our understanding of the cumulative interactive effects of exposures to chemical and non-chemical stressors in the built, natural, physical, and social environments on adverse pregnancy and health outcomes in vulnerable populations., The Institute for Health Disparities, Equity and the Exposome at Meharry Medical College and researchers at The Ohio State University would like to acknowledge partial support from USEPA STAR Grant# G17D112354237 for Co-Principal Investigator Darryl B. Hood, and Co-Investigator Cynthia Colen. We also acknowledge support for N.P. from The European Research Council (ERC) Consolidator Grant 770827 and The Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results., Peer Reviewed, "Article signat per 16 autors/es: Myriam Patricia Cifuentes, Clara Mercedes Suarez, Ricardo Cifuentes, Noel Malod-Dognin ,Sam Windels, Jose Fernando Valderrama ,Paul D. Juarez, R. Burciaga Valdez ,Cynthia Colen,Charles Phillips,Aramandla Ramesh,Wansoo Im ,Maureen Lichtveld, Charles Mouton,Nataša Pržulj and Darryl B. Hood ", Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identifying cellular cancer mechanisms through pathway-driven data integration

  • Windels, Sam F
  • Malod Dognin, Noël
  • Pržulj, Nataša
Motivation Cancer is a genetic disease in which accumulated mutations of driver genes induce a functional reorganization of the cell by reprogramming cellular pathways. Current approaches identify cancer pathways as those most internally perturbed by gene expression changes. However, driver genes characteristically perform hub roles between pathways. Therefore, we hypothesize that cancer pathways should be identified by changes in their pathway–pathway relationships. Results To learn an embedding space that captures the relationships between pathways in a healthy cell, we propose pathway-driven non-negative matrix tri-factorization. In this space, we determine condition-specific (i.e. diseased and healthy) embeddings of pathways and genes. Based on these embeddings, we define our ‘NMTF centrality’ to measure a pathway’s or gene’s functional importance, and our ‘moving distance’, to measure the change in its functional relationships. We combine both measures to predict 15 genes and pathways involved in four major cancers, predicting 60 gene–cancer associations in total, covering 28 unique genes. To further exploit driver genes’ tendency to perform hub roles, we model our network data using graphlet adjacency, which considers nodes adjacent if their interaction patterns form specific shapes (e.g. paths or triangles). We find that the predicted genes rewire pathway–pathway interactions in the immune system and provide literary evidence that many are druggable (15/28) and implicated in the associated cancers (47/60). We predict six druggable cancer-specific drug targets., This work was supported by the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 [grant number PID2019-105500GB-I00]., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Multi-omics integration of scRNA-seq time series data predicts new intervention points for Parkinson’s disease

  • Mihajlović, Katarina
  • Ceddia, Gaia
  • Malod Dognin, Noël
  • Novak, Gabriela
  • Kyriakis, Dimitrios
  • Skupin, Alexander
  • Przulj, Natasa
Parkinson’s disease (PD) is a complex neurodegenerative disorder without a cure. The onset of PD symptoms corresponds to 50% loss of midbrain dopaminergic (mDA) neurons, limiting early-stage understanding of PD. To shed light on early PD development, we study time series scRNA-seq datasets of mDA neurons obtained from patient-derived induced pluripotent stem cell differentiation. We develop a new data integration method based on Non-negative Matrix Tri-Factorization that integrates these datasets with molecular interaction networks, producing condition-specific “gene embeddings”. By mining these embeddings, we predict 193 PD-related genes that are largely supported (49.7%) in the literature and are specific to the investigated PINK1 mutation. Enrichment analysis in Kyoto Encyclopedia of Genes and Genomes pathways highlights 10 PD-related molecular mechanisms perturbed during early PD development. Finally, investigating the top 20 prioritized genes reveals 12 previously unrecognized genes associated with PD that represent interesting drug targets., This project has received funding from the European Union’s EU Framework Programme for Research and Innovation Horizon 2020, Grant Agreement No 860895, the European Research Council (ERC) Consolidator Grant 770827, the Spanish State Research Agency and the Ministry of Science and Innovation MCIN grant PID2019-105500GB-I00 / AEI / 10.13039/501100011033 and grant PID2022-141920NB-I00 / AEI /10.13039/501100011033/ FEDER, UE, and the Department of Research and Universities of the Generalitat de Catalunya code 2021 SGR 01536. DK was supported by the PRIDE program of the Luxembourg National Research Fund through PRIDE17/12244779/PARK-QC., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Graphlet-based hyperbolic embeddings capture evolutionary dynamics in genetic networks

  • Windels, Sam F L
  • Tello Velázquez, Daniel
  • Rotkevich, Mikhail
  • Malod Dognin, Noël
  • Przulj, Natasa
Motivation Spatial Analysis of Functional Enrichment (SAFE) is a popular tool for biologists to investigate the functional organization of biological networks via highly intuitive 2D functional maps. To create these maps, SAFE uses Spring embedding to project a given network into a 2D space in which nodes connected in the network are near each other in space. However, many biological networks are scale-free, containing highly connected hub nodes. Because Spring embedding fails to separate hub nodes, it provides uninformative embeddings that resemble a ‘hairball’. In addition, Spring embedding only captures direct node connectivity in the network and does not consider higher-order node wiring patterns, which are best captured by graphlets, small, connected, nonisomorphic, induced subgraphs. The scale-free structure of biological networks is hypothesized to stem from an underlying low-dimensional hyperbolic geometry, which novel hyperbolic embedding methods try to uncover. These include coalescent embedding, which projects a network onto a 2D disk. Results To better capture the functional organization of scale-free biological networks, whilst also going beyond simple direct connectivity patterns, we introduce Graphlet Coalescent (GraCoal) embedding, which embeds nodes nearby on a disk if they frequently co-occur on a given graphlet together. We use GraCoal to extend SAFE-based network analysis. Through SAFE-enabled enrichment analysis, we show that GraCoal outperforms graphlet-based Spring embedding in capturing the functional organization of the genetic interaction networks of fruit fly, budding yeast, fission yeast and Escherichia coli. We show that depending on the underlying graphlet, GraCoal embeddings capture different topology-function relationships. We show that triangle-based GraCoal embedding captures functional redundancies between paralogs., This work was supported by the European Research Council (ERC) Consolidator Grant [770827] and the Spanish State Research Agency AEI 10.13039/501100011033 grant number [PID2019-105500GB-I00]., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

A functional analysis of omic network embedding spaces reveals key altered functions in cancer

  • Doria Belenguer, Sergio
  • Xenos, Alexandros
  • Ceddia, Gaia
  • Malod Dognin, Noël
  • Pržulj, Nataša
Abstract Motivation Advances in omics technologies have revolutionized cancer research by producing massive datasets. Common approaches to deciphering these complex data are by embedding algorithms of molecular interaction networks. These algorithms find a low-dimensional space in which similarities between the network nodes are best preserved. Currently available embedding approaches mine the gene embeddings directly to uncover new cancer-related knowledge. However, these gene-centric approaches produce incomplete knowledge, since they do not account for the functional implications of genomic alterations. We propose a new, function-centric perspective and approach, to complement the knowledge obtained from omic data. Results We introduce our Functional Mapping Matrix (FMM) to explore the functional organization of different tissue-specific and species-specific embedding spaces generated by a Non-negative Matrix Tri-Factorization algorithm. Also, we use our FMM to define the optimal dimensionality of these molecular interaction network embedding spaces. For this optimal dimensionality, we compare the FMMs of the most prevalent cancers in human to FMMs of their corresponding control tissues. We find that cancer alters the positions in the embedding space of cancer-related functions, while it keeps the positions of the noncancer-related ones. We exploit this spacial ‘movement’ to predict novel cancer-related functions. Finally, we predict novel cancer-related genes that the currently available methods for gene-centric analyses cannot identify; we validate these predictions by literature curation and retrospective analyses of patient survival data., This project has received funding from the European Research Council (ERC) Consolidator Grant 770827 and the Spanish State Research Agency AEI 10.13039/501100011033 grant number PID2019-105500GB-I00., Peer Reviewed, Postprint (published version)